Process for precipitating a carbonate or (oxy)hydroxide comprising nickel from an aqueous solution of a nickel salt wherein such process is carried out in a vessel comprising (A) a vessel body, (B) one or more elements that control the hydraulic flow of the slurry formed during the precipitation and that induce a loop-type circulation flow, and (C) a stirrer whose stirrer element is in the vessel but located separately from the element(s) (B).

A process for producing a metal oxide powder comprising: providing a precursor solution or dispersion containing a metal complex; spraying the precursor solution on to a heated substrate in the presence of water, thereby depositing material on the substrate; drying the deposited material; and removing the deposited material from the substrate to produce the metal oxide powder.

A process for producing a metal oxide powder comprising: providing a precursor solution or dispersion containing a metal complex; spraying the precursor solution on to a heated substrate in the presence of water, thereby depositing material on the substrate; drying the deposited material; and removing the deposited material from the substrate to produce the metal oxide powder.

The present invention relates to a magnetic resonance imaging (MRI) contrast agent, particularly a metal oxide nanoparticle-based T1-T2 dual-mode MRI contrast agent that can be used not only as a T1 MRI contrast agent but also as a T2 MRI contrast agent, and a method for producing the same. The metal oxide nanoparticle-based T1-T2 dual-mode MRI contrast agent can provide more accurate and detailed information associated with disease than single MRI contrast agent by the beneficial contrast effects in both T1 imaging with high tissue resolution and T2 imaging with high feasibility on detection of a lesion.

The present invention relates to a magnetic resonance imaging (MRI) contrast agent, particularly a metal oxide nanoparticle-based T1-T2 dual-mode MRI contrast agent that can be used not only as a T1 MRI contrast agent but also as a T2 MRI contrast agent, and a method for producing the same. The metal oxide nanoparticle-based T1-T2 dual-mode MRI contrast agent can provide more accurate and detailed information associated with disease than single MRI contrast agent by the beneficial contrast effects in both T1 imaging with high tissue resolution and T2 imaging with high feasibility on detection of a lesion.

A method for making a catalyst for ozone decomposition includes: adding a reducing agent into a water solution of a permanganate salt to obtain a first reaction liquid, and heating the first reaction liquid under continuous stirring to form a birnessite-type manganese dioxide; and adding the birnessite-type manganese dioxide into a water solution of an ammonium salt to obtain a second reaction liquid, and heating the second reaction liquid under continuous stirring to form the catalyst.

A method of manufacturing a battery electrode material in slurry form to be coated on a sheet-shaped current collector, the battery electrode material containing an electrode active material made of electrolytic manganese dioxide (EMD) and containing an aqueous binder. The method includes, as a process of mixing and kneading raw materials of the battery electrode material by using water as a solvent, mixing the electrode active material; mixing the binder; and mixing a neutralizing agent, the neutralizing agent being lithium hydroxide (LiOH).

A method of manufacturing a battery electrode material in slurry form to be coated on a sheet-shaped current collector, the battery electrode material containing an electrode active material made of electrolytic manganese dioxide (EMD) and containing an aqueous binder. The method includes, as a process of mixing and kneading raw materials of the battery electrode material by using water as a solvent, mixing the electrode active material; mixing the binder; and mixing a neutralizing agent, the neutralizing agent being lithium hydroxide (LiOH).

A method of regenerating an etch solution comprising a metastable complex of manganese(III) ions in a strong acid is described in which at least a portion of the manganese(III) ions in the metastable complex have been destabilized, causing them to disproportionate into manganese dioxide and manganese(II) ions. The method includes the steps of i) adding an effective amount of a reducing agent to the solution; ii) allowing the reducing agent to react with the solution to cause manganese dioxide to dissolve; and (iii) applying an electrical current to regenerate manganese(III) ions in the solution.

A method of regenerating an etch solution comprising a metastable complex of manganese(III) ions in a strong acid is described in which at least a portion of the manganese(III) ions in the metastable complex have been destabilized, causing them to disproportionate into manganese dioxide and manganese(II) ions. The method includes the steps of i) adding an effective amount of a reducing agent to the solution; ii) allowing the reducing agent to react with the solution to cause manganese dioxide to dissolve; and (iii) applying an electrical current to regenerate manganese(III) ions in the solution.